Utah Medical Products
UTMD
77 hedge funds and large institutions have $221M invested in Utah Medical Products in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 9 closing their positions.
5% more capital invested
Capital invested by funds: $210M → $221M (+$11M)
0.83% less ownership
Funds ownership: 72.83% → 72% (-0.83%)
9% less funds holding
Funds holding: 85 → 77 (-8)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.27M |
| 2 |
JP Morgan Chase
New York
|
+$1.22M |
| 3 |
BlackRock
New York
|
+$626K |
| 4 |
Renaissance Technologies
New York
|
+$590K |
| 5 |
Goldman Sachs
New York
|
+$514K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Natixis Advisors
Boston,
Massachusetts
|
-$1.08M |
| 2 |
Millennium Management
New York
|
-$907K |
| 3 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$863K |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$808K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$787K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIG
76
American International Group
New York
| $167 | -$4.77K | -56 | -3% |
|
|
77
Natixis Advisors
Boston,
Massachusetts
| – | -$1.08M | -13,533 | Closed |
|
|
MAM
78
Martingale Asset Management
Boston,
Massachusetts
| – | -$863K | -10,802 | Closed |
|
79
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$605K | -7,571 | Closed |
|
80
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$576K | -7,207 | Closed |
|
81
Prudential Financial
Newark,
New Jersey
| – | -$347K | -4,350 | Closed |
|
82
Citadel Advisors
Miami,
Florida
| – | -$227K | -2,833 | Closed |
|
83
DZ Bank
Frankfurt Am Main,
Germany
| – | -$95.9K | -1,201 | Closed |
|
|
GT
84
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$1K | -19 | Closed |
|
|
MAM
85
Meeder Asset Management
Dublin,
Ohio
| – | -$1K | -16 | Closed |
|
|
MA
86
MUFG Americas
New York
| – | +$426 | +5 | New |
|
UTMD Hedge Fund Activity: Q4 2020 in Review
77 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2020, worth a combined $221M — up 5.3% from $210M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of UTMD and 1 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 26 added.
The largest buyer was Vanguard Group, adding an estimated $1.27M. The largest seller was Natixis Advisors, exiting entirely with an estimated $1.08M sold.
- 77 institutional investors held Utah Medical Products (UTMD) as of Q4 2020, down from 85 in Q3 2020.
- Funds reported $221M of Utah Medical Products stock for Q4 2020, up 5.3% quarter-over-quarter.
- 1 fund opened new Utah Medical Products positions in Q4 2020 and 9 closed out, a net change of -8 holders.
- The largest Utah Medical Products buyer in Q4 2020 was Vanguard Group, an estimated $1.27M added.
- The largest Utah Medical Products seller in Q4 2020 was Natixis Advisors, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2020.